Drug Transporters and Multiple Drug Resistance in the Most Common Pediatric Solid Tumors

Author(s): Doriana Fruci, William C.S. Cho, Paolo Romania, Valerio Nobili, Franco Locatelli, Anna Alisi

Journal Name: Current Drug Metabolism

Volume 17 , Issue 4 , 2016

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Solid tumors account for approximately 30% of all pediatric cancers. Although chemotherapy has largely contributed to strongly improve patient outcome, multidrug resistance (MDR) remains one of the major mechanisms limiting the overall survival. The enhanced efflux rate of chemotherapeutic drugs from tumor cells through drug transporters is one of the most important mechanisms of MDR. Drug transporters play a pivotal role in preserving the balance between sensitivity and resistance of tumor cells to anti-neoplastic drugs. Their functional activities have been barely investigated in pediatric solid malignancies. Here, we provide evidence from the current literatures on drug transporters and MDR in the most common types of pediatric solid tumors, including neuroblastoma, Wilms’ tumor, rhabdomyosarcoma, retinoblastoma, medulloblastoma and hepatoblastoma.

Keywords: ABC transporters, MDR1, MRP1, Multidrug resistance, neoadjuvant chemotherapy, pediatric solid tumors.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2016
Page: [308 - 316]
Pages: 9
DOI: 10.2174/1567205010666131212110948
Price: $65

Article Metrics

PDF: 56
PRC: 1